MedTrace Logo

Oxytocin's Effect on the Advantageous- and Disadvantageous-inequity

NCT06405737 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-08-14

No results posted yet for this study

Summary

The main aim of the study is to investigate whether intranasal oxytocin modulates advantageous- and disadvantageous-inequity and whether oxytocin has similar effects on them or not.

Conditions

  • Healthy

Interventions

DRUG

Intranasal oxytocin

Subject assigned to receive intranasal administration of oxytocin (24 IU).

DRUG

Intranasal placebo

Subjects assigned to receive intranasal administration of placebo (24 IU).

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Principal Investigators

  • Yao Shuxia, Dr · University of Electronic Science and Technology of China

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-07
Primary Completion
2024-06-12
Completion
2024-06-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06405737 on ClinicalTrials.gov